The Asia Pacific Antiseptics and Disinfectants market is forecasted to grow 1.90 billion by 2026 from USD 1.30 billion in 2021. The market is estimated to grow at a 7.92% CAGR from 2021 to 2026. The rise in the number of surgeries and the growing demand for antiseptics & disinfectants are fueling the market's growth. Also, change in government policies in favor of the poor people, especially during the COVID-19 outbreak, elevates the demand of the market.
Increasing the scale of hospitals and clinics across the region, the rising flow of patients, the rising prevalence of surgical treatment procedures, and the need to keep the instruments sterile to prevent bacteria's growth are the primary growth driving factors to the Asia Pacific Surface Disinfectants Market. Furthermore, increasing support from government organizations through funds and creating awareness through campaigns broadens the growth rate of the market in the Asia Pacific.
Awareness towards the prevention of microbe growth in medical devices through antiseptics and disinfectants, rising focus to improve healthcare services in hospitals and clinics to promote the wellbeing of the patient is straight propelling the growth rate of the antiseptics and disinfectants market in this region.
However, fluctuations in the production rate of these products in manufacturing companies are slowly impeding the market demand. The dearth of skilled staff in keeping surgical instruments more hygienic in rural areas is challenging for market growth. Rapid changes in the government's economic strategies are also limiting the growth rate of the antiseptics and disinfectants market in the Asia Pacific. Lack of standardization is also hindering the demand of the market.
This report on the Asia Pacific antiseptics and disinfectants market has been segmented & sub-segmented into the following categories:
Geographically, the Asia Pacific has the largest population compared to the other geographies, and the safety concerns among all people are offering a high growth rate to this region.
The Indian antiseptics and disinfectants market is playing the leading role in the APAC market. Creating awareness through campaigns and digital media is lucratively lavishing the demand of the market. The growing geriatric population is an additional factor prompting the growth rate of the market in this country.
Following India, China is ruling with prominent shares of the market. Increasing demand to improve the healthcare infrastructure is majorly fuelling the growth rate of the market. Escalating expenditure on healthcare is prompting the growth rate of the market in this country.
The antiseptics and disinfectants market has great opportunities in Japan. Growing disposable income in urban areas is one of the factors anticipated to accelerate the market's demand. The rise in the incidences of various health disorders is propelling the growth rate of this market.
In the antiseptics and disinfectants market in Australia, the rise in the number of research and development institutes is a key factor elevating the demand of the antiseptics and disinfectants market. The growing prevalence of sanitizing properly in hospitals due to the spread of COVID-19 is escalating the market demand.
In South Korea, the demand for antiseptics and disinfectants is expected to have the highest growth rate in 2020-2025. The rising scale of healthcare centers is greatly influencing the demand of the market. Rise in the awareness over the use of antiseptics and disinfectants is leveling this market's demand.
Apart from the above, countries like Thailand, Russia, and ASEAN countries to see significant growth due to the COVID-19 outbreak.
Promising companies in the APAC Antiseptics and Disinfectants Market profiled in this report are 3M Company, Abc Compounding, Advanced Sterilization Products, American Biotech Labs, Angelini Pharma Inc., Becton, Dickinson And Company, Bio-Cide International Inc., Cardinal Health and Carefusion Corp.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 End User
5.1.2 Domestic User
5.1.3 Institutional User
5.1.4 Y-o-Y Growth Analysis, By End User
5.1.5 Market Attractiveness Analysis, By End User
5.1.6 Market Share Analysis, By End User
5.2.2 Alcohol and Aldehyde
5.2.3 Phenols and Derivatives
5.2.4 Biguanides and Amides
5.2.5 Quaternary Ammonium Compounds
5.2.6 Iodine Compounds
5.2.8 Y-o-Y Growth Analysis, By Type
5.2.9 Market Attractiveness Analysis, By Type
5.2.10 Market Share Analysis, By Type
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By End User
184.108.40.206 By Type
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By End User
22.214.171.124 By Type
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By End User
184.108.40.206 By Type
6.5 South Korea
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 3M Company
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Abc Compounding
8.3 Advanced Sterilization Products
8.4 American Biotech Labs
8.5 Angelini Pharma Inc.
8.6 Becton, Dickinson And Company
8.7 Bio-Cide International Inc.
8.8 ICardinal Health
8.9 Carefusion Corp.
8.10 Nufarm Limited
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures